We recently published 12 Best Healthcare Stocks to Buy Under $30. MannKind Corporation (NASDAQ:MNKD) is one of the best ...

MannKind (NASDAQ:MNKD), a biopharmaceutical firm known for its inhaled insulin and pulmonary therapeutics, released its second quarter 2025 earnings on August 6, 2025. The most si ...

Good morning, and welcome to the MannKind Corporation Second Quarter 2025 Financial Results Conference Call. As a reminder, this call is being recorded on August 6, 2025, and will be available for ...

MannKind saw decent growth from its two core products in Q2 and just signed a new non-dilutive financing agreement with ...

The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said ...

Modular Medical (Nasdaq:MODD) announced today that it validated its insulin pump cartridge line for human-use production in ...

In critically ill children requiring mechanical ventilation, inhaled isoflurane shows sedation efficacy comparable to the routinely used intravenous sedative midazolam.

GSK pays $500M to enter drugmaking alliance with Hengrui The deal, which could involve up to a dozen medicines and be worth as much as $12 billion, is the latest licensing pact involving ...

Tandem Diabetes Care sent an ‘Urgent Medical Device Correction’ letter regarding possible speaker failure and pump delivery failure.